Xultant Organosynth Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 6 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 3.00 M
About Xultant Organosynth
Xultant Organosynth Private Limited (XOPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 July 2003 and has a history of 21 years and six months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹3.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mitu Patodia and Ramesh Patodia serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U72900MH2003PTC141513
-
Company No.
141513
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Jul 2003
-
Date of AGM
28 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Xultant Organosynth?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Patodia
|
Director | 28-Jul-2003 | Current |
|
Mitu Patodia
|
Director | 28-Jul-2003 | Current |
Financial Performance of Xultant Organosynth.
Enhance accessibility to Xultant Organosynth's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Xultant Organosynth?
In 2016, Xultant Organosynth had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ambrosia Nutrition Private LimitedRamesh Patodia is a mutual person
Charges (Loans)
₹0
₹3.00 M
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Apr 2009 | Punjab National Bank | ₹3.00 M | Satisfied |
How Many Employees Work at Xultant Organosynth?
Unlock and access historical data on people associated with Xultant Organosynth, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xultant Organosynth, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xultant Organosynth's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.